These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21245439)

  • 1. Time-kill activity of the streptogramin NXL 103 against Gram-positive and -negative bacteria.
    Pankuch GA; Lin G; Clark C; Appelbaum PC
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1787-91. PubMed ID: 21245439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
    Peric M; Browne FA; Jacobs MR; Appelbaum PC
    Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.
    Clark C; McGhee P; Appelbaum PC; Kosowska-Shick K
    Antimicrob Agents Chemother; 2011 May; 55(5):2344-51. PubMed ID: 21343467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal kinetics and postantibiotic effect of sparfloxacin against selected species of respiratory pathogens.
    Speciale A; Blandino G; Nicolosi VM; Siracusa V; Caccamo F
    J Chemother; 1995 Dec; 7(6):530-4. PubMed ID: 8667038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gepotidacin (GSK2140944)
    Flamm RK; Farrell DJ; Rhomberg PR; Scangarella-Oman NE; Sader HS
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.
    Ueda Y; Sunagawa M
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2471-80. PubMed ID: 12878507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro bactericidal activity of four oral antibiotics against pathogens responsible for acute otitis media in children.
    Lambert-Zechovsky N; Mariani-Kurkdjian P; Doit C; Bourgeois F; Bingen E
    J Hosp Infect; 1992 Nov; 22 Suppl A():89-97. PubMed ID: 1362754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria.
    Chamberland S; Blais J; Hoang M; Dinh C; Cotter D; Bond E; Gannon C; Park C; Malouin F; Dudley MN
    Antimicrob Agents Chemother; 2001 May; 45(5):1422-30. PubMed ID: 11302805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antibacterial activity of modithromycin, a novel 6,11-bridged bicyclolide, against respiratory pathogens, including macrolide-resistant Gram-positive cocci.
    Sato T; Tateda K; Kimura S; Iwata M; Ishii Y; Yamaguchi K
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1588-93. PubMed ID: 21220534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of a new oral streptogramin, XRP 2868, compared to those of other agents against Streptococcus pneumoniae and haemophilus species.
    Pankuch GA; Kelly LM; Lin G; Bryskier A; Couturier C; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3270-4. PubMed ID: 14506040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983.
    Forsgren A; Walder M
    Acta Otolaryngol Suppl; 1984; 407():43-9. PubMed ID: 6437134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases.
    Biedenbach DJ; Beach ML; Jones RN
    Diagn Microbiol Infect Dis; 2001 Aug; 40(4):173-7. PubMed ID: 11576790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy of streptogramin antibiotics occurs independently of their effects on translation.
    Noeske J; Huang J; Olivier NB; Giacobbe RA; Zambrowski M; Cate JH
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5269-79. PubMed ID: 24957822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity and accumulation of moxifloxacin in quinolone-susceptible bacteria.
    Piddock LJ; Jin YF
    J Antimicrob Chemother; 1999 May; 43 Suppl B():39-42. PubMed ID: 10382874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria.
    Malathum K; Coque TM; Singh KV; Murray BE
    Antimicrob Agents Chemother; 1999 Apr; 43(4):930-6. PubMed ID: 10103202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
    Pfaller MA; Farrell DJ; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
    Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.